Nothing Special   »   [go: up one dir, main page]

FI922515A - Foerbaettrad foerfarande foer att producera glykosyltransferaser - Google Patents

Foerbaettrad foerfarande foer att producera glykosyltransferaser Download PDF

Info

Publication number
FI922515A
FI922515A FI922515A FI922515A FI922515A FI 922515 A FI922515 A FI 922515A FI 922515 A FI922515 A FI 922515A FI 922515 A FI922515 A FI 922515A FI 922515 A FI922515 A FI 922515A
Authority
FI
Finland
Prior art keywords
glykosyltransferaser
foerbaettrad
foerfarande foer
foer att
producera
Prior art date
Application number
FI922515A
Other languages
English (en)
Other versions
FI922515A0 (fi
Inventor
Gabriele Watzele
Eric G Berger
Bernd Meyhack
Manfred Watzele
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9208211A external-priority patent/GB2256197B/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI922515A0 publication Critical patent/FI922515A0/fi
Publication of FI922515A publication Critical patent/FI922515A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1051Hexosyltransferases (2.4.1)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI922515A 1991-05-31 1992-05-29 Foerbaettrad foerfarande foer att producera glykosyltransferaser FI922515A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP91810414 1991-05-31
EP92810167 1992-03-04
GB9208211A GB2256197B (en) 1991-05-31 1992-04-14 Yeast as host for expression of heterologous glycosyl transferase enzymes

Publications (2)

Publication Number Publication Date
FI922515A0 FI922515A0 (fi) 1992-05-29
FI922515A true FI922515A (fi) 1992-12-01

Family

ID=27234292

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922515A FI922515A (fi) 1991-05-31 1992-05-29 Foerbaettrad foerfarande foer att producera glykosyltransferaser

Country Status (19)

Country Link
JP (1) JPH05199871A (fi)
AT (1) AT401940B (fi)
AU (1) AU655470B2 (fi)
BE (1) BE1005579A5 (fi)
CA (1) CA2070057A1 (fi)
DK (1) DK71992A (fi)
ES (1) ES2046118B1 (fi)
FI (1) FI922515A (fi)
GR (1) GR920100250A (fi)
HU (1) HU212927B (fi)
IE (1) IE69059B1 (fi)
IL (1) IL102052A0 (fi)
IT (1) IT1255044B (fi)
LU (1) LU88123A1 (fi)
MX (1) MX9202583A (fi)
NO (1) NO922134L (fi)
NZ (1) NZ242958A (fi)
PT (1) PT100545A (fi)
SE (1) SE9201544L (fi)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8716240B2 (en) 2001-10-10 2014-05-06 Novo Nordisk A/S Erythropoietin: remodeling and glycoconjugation of erythropoietin
US8716239B2 (en) 2001-10-10 2014-05-06 Novo Nordisk A/S Granulocyte colony stimulating factor: remodeling and glycoconjugation G-CSF
US8791066B2 (en) 2004-07-13 2014-07-29 Novo Nordisk A/S Branched PEG remodeling and glycosylation of glucagon-like peptide-1 [GLP-1]
US8841439B2 (en) 2005-11-03 2014-09-23 Novo Nordisk A/S Nucleotide sugar purification using membranes
US8853161B2 (en) 2003-04-09 2014-10-07 Novo Nordisk A/S Glycopegylation methods and proteins/peptides produced by the methods
US8911967B2 (en) 2005-08-19 2014-12-16 Novo Nordisk A/S One pot desialylation and glycopegylation of therapeutic peptides
US8916360B2 (en) 2003-11-24 2014-12-23 Novo Nordisk A/S Glycopegylated erythropoietin
US8969532B2 (en) 2006-10-03 2015-03-03 Novo Nordisk A/S Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
US9005625B2 (en) 2003-07-25 2015-04-14 Novo Nordisk A/S Antibody toxin conjugates
US9029331B2 (en) 2005-01-10 2015-05-12 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
US9050304B2 (en) 2007-04-03 2015-06-09 Ratiopharm Gmbh Methods of treatment using glycopegylated G-CSF
US9150848B2 (en) 2008-02-27 2015-10-06 Novo Nordisk A/S Conjugated factor VIII molecules
US9187532B2 (en) 2006-07-21 2015-11-17 Novo Nordisk A/S Glycosylation of peptides via O-linked glycosylation sequences
US9187546B2 (en) 2005-04-08 2015-11-17 Novo Nordisk A/S Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
US9200049B2 (en) 2004-10-29 2015-12-01 Novo Nordisk A/S Remodeling and glycopegylation of fibroblast growth factor (FGF)
US9493499B2 (en) 2007-06-12 2016-11-15 Novo Nordisk A/S Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE7819584U1 (de) * 1978-06-30 1978-10-12 Howmedica International, Inc. Zweigniederlassung Kiel, 2301 Schoenkirchen Tubenartiger vorratsbehaelter fuer medizinisches spritzgeraet
WO1993018157A1 (en) * 1992-03-09 1993-09-16 The Regents Of The University Of California Compositions and methods for the identification and synthesis of sialyltransferases
CA2405958C (en) * 2000-04-13 2011-08-09 Biotica Technology Limited Hybrid glycosylated products and their production and use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY103358A (en) * 1987-04-15 1993-06-30 Novartis Ag Process for the production of protiens.
WO1990007000A2 (en) * 1988-12-13 1990-06-28 La Jolla Cancer Research Foundation Nucleotides encoding human b1, 4-galactosyltransferase and uses thereof
US5032519A (en) * 1989-10-24 1991-07-16 The Regents Of The Univ. Of California Method for producing secretable glycosyltransferases and other Golgi processing enzymes
EP0515536B1 (en) * 1990-02-14 2000-01-19 The Regents Of The University Of Michigan Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules
EP0485532A1 (en) * 1990-04-27 1992-05-20 Biogen, Inc. Fucosyl transferases involved in adhesion molecule expression
DE4028800A1 (de) * 1990-09-11 1992-03-12 Behringwerke Ag Gentechnische sialylierung von glykoproteinen

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8716239B2 (en) 2001-10-10 2014-05-06 Novo Nordisk A/S Granulocyte colony stimulating factor: remodeling and glycoconjugation G-CSF
US8716240B2 (en) 2001-10-10 2014-05-06 Novo Nordisk A/S Erythropoietin: remodeling and glycoconjugation of erythropoietin
US8853161B2 (en) 2003-04-09 2014-10-07 Novo Nordisk A/S Glycopegylation methods and proteins/peptides produced by the methods
US9005625B2 (en) 2003-07-25 2015-04-14 Novo Nordisk A/S Antibody toxin conjugates
US8916360B2 (en) 2003-11-24 2014-12-23 Novo Nordisk A/S Glycopegylated erythropoietin
US8791066B2 (en) 2004-07-13 2014-07-29 Novo Nordisk A/S Branched PEG remodeling and glycosylation of glucagon-like peptide-1 [GLP-1]
US10874714B2 (en) 2004-10-29 2020-12-29 89Bio Ltd. Method of treating fibroblast growth factor 21 (FGF-21) deficiency
US9200049B2 (en) 2004-10-29 2015-12-01 Novo Nordisk A/S Remodeling and glycopegylation of fibroblast growth factor (FGF)
US9029331B2 (en) 2005-01-10 2015-05-12 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
US9187546B2 (en) 2005-04-08 2015-11-17 Novo Nordisk A/S Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
US8911967B2 (en) 2005-08-19 2014-12-16 Novo Nordisk A/S One pot desialylation and glycopegylation of therapeutic peptides
US8841439B2 (en) 2005-11-03 2014-09-23 Novo Nordisk A/S Nucleotide sugar purification using membranes
US9187532B2 (en) 2006-07-21 2015-11-17 Novo Nordisk A/S Glycosylation of peptides via O-linked glycosylation sequences
US8969532B2 (en) 2006-10-03 2015-03-03 Novo Nordisk A/S Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
US9050304B2 (en) 2007-04-03 2015-06-09 Ratiopharm Gmbh Methods of treatment using glycopegylated G-CSF
US9493499B2 (en) 2007-06-12 2016-11-15 Novo Nordisk A/S Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography
US9150848B2 (en) 2008-02-27 2015-10-06 Novo Nordisk A/S Conjugated factor VIII molecules

Also Published As

Publication number Publication date
AU655470B2 (en) 1994-12-22
DK71992D0 (da) 1992-05-29
LU88123A1 (de) 1993-12-06
IL102052A0 (en) 1992-12-30
HUT65728A (en) 1994-07-28
DK71992A (da) 1992-12-01
NO922134D0 (no) 1992-05-29
PT100545A (pt) 1993-08-31
NZ242958A (en) 1993-06-25
ITRM920411A0 (it) 1992-05-29
NO922134L (no) 1992-12-01
MX9202583A (es) 1992-11-01
ITRM920411A1 (it) 1993-11-29
ES2046118A1 (es) 1994-01-16
FI922515A0 (fi) 1992-05-29
ES2046118B1 (es) 1994-08-16
GR920100250A (el) 1993-03-31
BE1005579A5 (fr) 1993-11-09
ATA112792A (de) 1996-05-15
IE921769A1 (en) 1992-12-02
IE69059B1 (en) 1996-08-07
SE9201544L (sv) 1992-12-01
CA2070057A1 (en) 1992-12-01
HU212927B (en) 1996-12-30
IT1255044B (it) 1995-10-17
SE9201544D0 (sv) 1992-05-15
AT401940B (de) 1996-12-27
JPH05199871A (ja) 1993-08-10
HU9201787D0 (en) 1992-08-28
AU1705292A (en) 1992-12-03

Similar Documents

Publication Publication Date Title
FI925383A0 (fi) Arrangemang foer att erhaolla nyckelparametrar foer bestyrkning i cellulaert mobiltelefoninaet
ATE137279T1 (de) Stoffauflauf
ATA131391A (de) Reibring
FI922515A (fi) Foerbaettrad foerfarande foer att producera glykosyltransferaser
FI933990A (fi) Anordning foer att tillverka en torkad pappersbana
FI923607A (fi) Foerbaettringar i pulpmaskiner foer att dispergera sellulosapulp
FI934710A0 (fi) 4-aryl-3-(heteroarylureido)kinolinderivat
ATA170491A (de) Mauerstein
ATA39792A (de) Maehwerk
FI925038A (fi) Anordning i spegel foer att foehindra fuktbildning
FI914746A (fi) Foerfarande foer att utfoera en anslutningsjaemning
ATE163916T1 (de) Ethyl-6-formyloxy-4-hexenoat
FI921131A (fi) Foerfarande foer att realisera inbindningselement
ATA9892A (de) Formstein
ATA67791A (de) Rollski
FI931734A0 (fi) Anordning foer att distribuera foeremaol till teknologiska behandlingslinjer
FI88683C (fi) Anordning foer att skaera begagnade slipskivor foer nyanvaendning
FI916086A (fi) Anordning foer att loesgoera betongelement fraon en form
SE9103005D0 (sv) Saett att aastadkomma en kornisch
BR7102405U (pt) Chutegol
BR9104106A (pt) Teleoferta
ATA90791A (de) Manchon
BR7102174U (pt) Refresqueira
BR7100443U (pt) Vigier
BR7100567U (pt) Auto-transponder

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FD Application lapsed